For Bronchiectasis
Gain objective insights into cough burden in bronchectasis patients
Cough is not just a symptom in bronchiectasis; it is one of the most distressing and persistent clinical features.
-
Up to 90% of patients with bronchiectasis report daily coughing, often with sputum production¹
-
Frequent cough is strongly linked to poorer quality of life, increased airway infection risk, and higher healthcare utilization.²
-
Traditional measures (spirometry, imaging, and patient-reported outcomes) often fail to capture the real-world frequency, severity, and timing of cough.³
For drug developers and clinicians, this gap presents both a clinical challenge and an opportunity: objective cough monitoring can provide granular insights into how treatments impact patient lives.
The RESP® Platform for Cough Monitoring
The RESP® Platform is a next-generation, high-fidelity cough monitoring system designed to provide greater insight into patient cough burden in daily life. Our technology offers:
- Flexible device selection for various cough monitoring applications
- Direct cloud syncs that expedite analysis of cough measures and streamline patient reports
- Comprehensive cough insights such as cough frequency, bouts and intensity
RESP® Biosensor
FDA-cleared medical device designed for high-fidelity, multi-dimensional cough monitoring.
- 24-hour cough frequency
- Cough sound intensity
- Cough bouts
- Sleep/wake*
- Activity levels*
- FDA 510(k) Clearance
- CE-marking
Watch-Based Cough Monitoring
Wrist-based device designed for seamless, multi-day cough monitoring. For research use only.
- 24-hour cough frequency*
- Cough bouts*
- Heart Rate*
- Respiratory Rate*
- SPO2*
- Skin temperature*
- Sleep Stages*
*Measurement not FDA cleared but may be used in clinical trials
Why the RESP® Platform for Bronchiectasis Patients?
Privacy & Security
Incorporates end-to-end encryption and speech obfuscation to preserve patient privacy
Wireless Data Sync
Cloud-based syncs from paired mobile phones allow for remote data uploads, accelerating subject reporting
High Fidelity & Accuracy
FDA 510(k) class II medical device for capturing lung sounds, including cough
Patient-Friendly
Wireless, discreet biosensor secured by a gentle and breathable adhesive
Advanced Insights
Gain a greater understanding of cough burden beyond cough counts, including cough intensity, breathing patterns, vitals, and other physiological data.
Publications
OVERVIEW VIDEO
Learn more about the benefits of the RESP® Biosensor for Bronchiectasis patients
Let’s Connect
Explore using the RESP® Biosensor in your study or practice
References
- Spinou A, Lee KK, et al. The validity of the Leicester Cough Questionnaire in bronchiectasis. Eur Respir J. 2017;49(3):1601532.
- Chalmers JD, et al. The impact of chronic cough in bronchiectasis: relationship to disease severity, quality of life, and exacerbations. Chest. 2014;145(5):974–982.
- McGuinness G, Naidich DP. Bronchiectasis: CT evaluation. AJR Am J Roentgenol. 2002;179(5):1241–1248.
- Guan W, et al. Symptoms predict future risk of exacerbations in adults with bronchiectasis: a multicentre prospective cohort study. Lancet Respir Med. 2025. doi:10.1016/S2213-2600(25)00160-2